Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension—A randomized, open‐label, active‐controlled, superiority, parallel‐group clinical trial

BACKGROUND: It has been suggested that renoprotection with calcium channel blockers (CCBs) may differ. This study aimed to compare the anti‐proteinuric effect of different CCBs in patients with type 2 diabetes (T2D). METHODS: A multicentre, randomized, open‐label, active‐controlled study was perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, You‐Cheol, Yoon, Kun‐Ho, Cha, Bong‐Soo, Lee, Kwan‐Woo, Jang, Hak Chul, Min, Kyung Wan, Chung, Choon Hee, Lee, Moon‐Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637912/
https://www.ncbi.nlm.nih.gov/pubmed/28840637
http://dx.doi.org/10.1111/ijcp.12987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637912/
https://www.ncbi.nlm.nih.gov/pubmed/28840637
http://dx.doi.org/10.1111/ijcp.12987

Ejemplares similares